Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells
Suman Suman, Trinath P. Das, Suman Sirimulla, et al.
Oncotarget (2016) Vol. 7, Iss. 12, pp. 13854-13864
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
Amit Choudhari, Pallavi Mandave, Manasi Deshpande, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 829
Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer
Simona Gurzu, Camelia Silveanu, Annamária Fetykó, et al.
World Journal of Gastroenterology (2016) Vol. 22, Iss. 30, pp. 6764-6764
Open Access | Times Cited: 101
Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug
Behrouz Hassannia, Emilie Logie, Peter Vandenabeele, et al.
Biochemical Pharmacology (2019) Vol. 173, pp. 113602-113602
Open Access | Times Cited: 101
Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds
Abedul Haque, Daniel A. Brazeau, A.R.M. Ruhul Amin
European Journal of Cancer (2021) Vol. 149, pp. 165-183
Open Access | Times Cited: 92
Proinflammatory Cytokines IL-6 and TNF-αIncreased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells
Seyung Chung, Yong Wu, Quincy Okobi, et al.
Mediators of Inflammation (2017) Vol. 2017, pp. 1-11
Open Access | Times Cited: 88
Evaluating anticancer properties of Withaferin A—a potent phytochemical
Maushma Atteeq
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42
Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling
Niraj Kumar Jha, Saniya Arfin, Saurabh Kumar Jha, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1086-1104
Open Access | Times Cited: 38
Phytocompounds targeting epigenetic modulations: an assessment in cancer
Aqsa Khan, Asifa Khan, Mohammad Aasif Khan, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 12
Molecular Characterization of Cancer Preventive and Therapeutic Potential of Three Antistress Compounds, Triethylene Glycol, Withanone, and Withaferin A
Huayue Zhang, Hyonchol Kim, Tian Yuan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 493-493
Open Access | Times Cited: 1
The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles
Mohammad‐Javad Sanaei, Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri‐Sigaroodi, et al.
Journal of Cellular Physiology (2021) Vol. 237, Iss. 3, pp. 1720-1752
Closed Access | Times Cited: 44
S···O and S···N Sulfur Bonding Interactions in Protein–Ligand Complexes: Empirical Considerations and Scoring Function
Mathew Koebel, Aaron Cooper, Grant Schmadeke, et al.
Journal of Chemical Information and Modeling (2016) Vol. 56, Iss. 12, pp. 2298-2309
Closed Access | Times Cited: 57
Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences
Yue Yu, Shashank P. Katiyar, Durai Sundar, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 4, pp. e2755-e2755
Open Access | Times Cited: 51
Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action
Anissa Nofita Sari, Priyanshu Bhargava, Jaspreet Kaur Dhanjal, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1160-1160
Open Access | Times Cited: 48
PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer
Khalid Saad Alharbi, Mohammad Arshad Javed Shaikh, Waleed Hassan Almalki, et al.
Journal of Environmental Pathology Toxicology and Oncology (2022) Vol. 41, Iss. 4, pp. 85-102
Open Access | Times Cited: 27
Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms
Zhichao Xing, Anping Su, Mi Li, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2909-2929
Open Access | Times Cited: 16
Colonic Injuries Induced by Inhalational Exposure to Particulate‐Matter Air Pollution
Xiaobo Li, Jian Cui, Hongbao Yang, et al.
Advanced Science (2019) Vol. 6, Iss. 11
Open Access | Times Cited: 40
The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis models
Balaji Chandrasekaran, Deeksha Pal, Venkatesh Kolluru, et al.
Carcinogenesis (2018) Vol. 39, Iss. 12, pp. 1537-1547
Open Access | Times Cited: 39
Phytotherapy Products and Active Principles
Camila Aline Romano, José Realino de Paula, Christianah A. Elusiyan, et al.
(2025), pp. 111-142
Closed Access
Anti-proliferation of triple-negative breast cancer cells with physagulide P: ROS/JNK signaling pathway induces apoptosis and autophagic cell death
Pei Yu, Chao Zhang, Caiyun Gao, et al.
Oncotarget (2017) Vol. 8, Iss. 38, pp. 64032-64049
Open Access | Times Cited: 36
Suppression of Notch1 and AKT mediated epithelial to mesenchymal transition by Verrucarin J in metastatic colon cancer
Deeksha Pal, Ashish Tyagi, Balaji Chandrasekaran, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 8
Open Access | Times Cited: 36
E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity
Irina Druzhkova, Nadezhda Ignatova, Н.Н. Проданец, et al.
Clinical Colorectal Cancer (2018) Vol. 18, Iss. 1, pp. e74-e86
Closed Access | Times Cited: 32
Molecular targets and mechanisms of anti-cancer effects of withanolides
Zhiruo Zhang, Yueying Yang, Yang Xu, et al.
Chemico-Biological Interactions (2023) Vol. 384, pp. 110698-110698
Closed Access | Times Cited: 9
Phyto‐therapeutic potential of Withania somnifera: Molecular mechanism and health implications
Nisha Yadav, Sandhya Tripathi, Neelam S. Sangwan
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1695-1714
Closed Access | Times Cited: 3
Molecular Insights into the Anticancer Activity of Withaferin-A: The Inhibition of Survivin Signaling
Renu Wadhwa, Jia Wang, Seyad Shefrin, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3090-3090
Open Access | Times Cited: 3
Drug‐like sphingolipid SH‐BC‐893 opposes ceramide‐induced mitochondrial fission and corrects diet‐induced obesity
Vaishali Jayashankar, Elizabeth Selwan, Sarah E. Hancock, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 8
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top